drugset / Trial / NCT02324335
Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Oral Mucositis (OM) is a painful and debilitating side effect of many of the drug/radiation regimens used to treat cancer. This study examines the investigational drug brilacidin and its possible application in prevention of oral mucositis in patients undergoing chemoradiation for treatment of head and neck cancer.
Timeline
- Start
- 2014-08-14
- Primary completion
- 2017-10-25
- Completion
- 2017-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brilacidin | Other / unclassified | 3 mg/ml | Oral |